Ana V. Marin, MSc, Anaïs Jiménez-Reinoso, MSc, Alejandro C

Slides:



Advertisements
Similar presentations
Ana V. Marin, MSc, Anaïs Jiménez-Reinoso, MSc, Alejandro C
Advertisements

Defective calcium signaling and disrupted CD20–B-cell receptor dissociation in patients with common variable immunodeficiency disorders  Annick A.J.M.
Combined immunodeficiency due to JAK3 mutation in a child presenting with skin granuloma  Alessia Scarselli, MD, Silvia Di Cesare, BSc, Gigliola Di Matteo,
Homozygous N-terminal missense mutation in TRNT1 leads to progressive B-cell immunodeficiency in adulthood  Glynis Frans, MPharm, Leen Moens, PhD, Heidi.
Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection 
Human TH17 cell development requires processing of dendritic cell–derived CXCL8 by neutrophil elastase  Yuri Souwer, PhD, Tom Groot Kormelink, PhD, Esther.
A case of partial dedicator of cytokinesis 8 deficiency with altered effector phenotype and impaired CD8+ and natural killer cell cytotoxicity  Raquel.
A novel mutation in CD132 causes X-CID with defective T-cell activation and impaired humoral reactivity  Taco W. Kuijpers, MD, PhD, Paul A. Baars, PhD,
CD4+ T cells in patients with chronic inflammatory rheumatic disorders show distinct levels of exhaustion  Theresa Frenz, PhD, Elena Grabski, PhD, Daniela.
Immunologic defects in 22q11.2 deletion syndrome
Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment  Federica Cattaneo, MD, Mike.
Analysis of somatic hypermutations in the IgM switch region in human B cells  Katsuyuki Horiuchi, MD, PhD, Kohsuke Imai, MD, PhD, Kanako Mitsui-Sekinaka,
FOXP3+ CD4 T-cell maturity and responses to microbial stimulation alter with age and associate with early-life gut colonization  Sophia Björkander, Maria.
RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease  Huawei Mao, MD, PhD, Wanling Yang, PhD, Sylvain Latour, PhD, Jing Yang, PhD,
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization  Silvia.
In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency 
Type 3 innate lymphoid cells induce proliferation of CD94+ natural killer cells  Shuo Li, PhD, Hideaki Morita, MD, PhD, Beate Rückert, Sci Tec, Tadech.
IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis  Stéphanie.
Jeff Choi, BSc, Rosemary Fernandez, PhD, Holden T
Flow cytometric measurement of STAT1 and STAT3 phosphorylation in CD4+ and CD8+ T cells—clinical applications in primary immunodeficiency diagnostics 
Surfactant protein D inhibits TNF-α production by macrophages and dendritic cells in mice  László Hortobágyi, MS, Sonja Kierstein, PhD, Kateryna Krytska,
CD19 controls Toll-like receptor 9 responses in human B cells
Beatriz Garcillán, MS, Marina S
Mass cytometry profiling the response of basophils and the complete peripheral blood compartment to peanut  Leticia Tordesillas, PhD, Adeeb H. Rahman,
Natural killer cell hyporesponsiveness and impaired development in a CD247-deficient patient  Mar Valés-Gómez, PhD, Gloria Esteso, PhD, Cigdem Aydogmus,
Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3–positive regulatory versus TH2 effector cells to.
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott-Aldrich syndrome  Junfeng Wu, MD, Dawei Liu, MS, Wenwei.
CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis  Esther Morel, PhD, Salvador Escamochero,
Differential expression of functional chemokine receptors on human blood and lung group 2 innate lymphoid cells  Cathryn A. Weston, PhD, Batika M.J. Rana,
Katherine G. MacDonald, BSc, Nicholas A. J
Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor–dependent innate antiviral immune responses  Douglas R. McDonald, MD, PhD,
Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid  Anne-Kathrin Kienzler, MSc, Marta Rizzi, MD,
Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated with a TH2-skewed immune response 
Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible.
Fibronectin is a TH1-specific molecule in human subjects
A thymic stromal lymphopoietin–responsive dendritic cell subset mediates allergic responses in the upper airway mucosa  Guro R. Melum, MD, Lorant Farkas,
Benjamin T. Prince, MD, Msci, Ashley L. Devonshire, MD, MPH, Kristin A
Chronic cat allergen exposure induces a TH2 cell–dependent IgG4 response related to low sensitization  Amedee Renand, PhD, Luis D. Archila, MSc, John.
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations  Giovanna.
Successful rapid rituximab desensitization in an adolescent patient with nephrotic syndrome: Increase in number of Treg cells after desensitization  Metin.
A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization.
Brent E. Palmer, PhD, Douglas G. Mack, PhD, Allison K
Anaïs Jiménez-Reinoso, PhD, Ana V
Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: Clinical and immunologic outcomes.
A novel LPS-responsive beige-like anchor protein (LRBA) mutation presents with normal cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and overactive.
Bet v 1–specific T-cell receptor/forkhead box protein 3 transgenic T cells suppress Bet v 1–specific T-cell effector function in an activation-dependent.
Peanut-specific type 1 regulatory T cells induced in vitro from allergic subjects are functionally impaired  Laurence Pellerin, PhD, Jennifer Anne Jenks,
Fibronectin is a TH1-specific molecule in human subjects
Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)  Kornvalee Meesilpavikkai,
IκB kinase–driven nuclear factor-κB activation in patients with asthma and chronic obstructive pulmonary disease  Rosalia Gagliardo, PhD, Pascal Chanez,
Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes  Rebeca Pérez de Diego, PhD, Eduardo López-Granados, MD, PhD,
Increased activation-induced cell death of high IFN-γ–producing TH1 cells as a mechanism of TH2 predominance in atopic diseases  Tunc Akkoc, PhD, Pieter.
Switched CD21–/low B cells with an antigen-presenting phenotype in the infant thymus  Christina Lundqvist, MSc, Alessandro Camponeschi, PhD, Marcella Visentini,
Dysregulated extracellular signal-regulated kinase signaling associated with impaired B- cell receptor endocytosis in patients with common variable immunodeficiency 
A novel hypomorphic mutation in STIM1 results in a late-onset immunodeficiency  Heidi Schaballie, MD, Rémy Rodriguez, MS, Emmanuel Martin, PhD, Leen Moens,
Sara Paveglio, PhD, MS, Erin Bennett, MS, Kelly L. Hawley, PhD, Adam P
Primary immunodeficiency disorder caused by phosphoinositide 3–kinase δ deficiency  Georgios Sogkas, MD, PhD, Mykola Fedchenko, MD, Akshay Dhingra, MSc,
Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency  Sayed Mahdi Marashi, PhD, Mohammed.
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells  Véronique Schulten, PhD, Victoria Tripple, BSc, Grégory Seumois,
Defining antigen-specific responses with human MHC class II tetramers
Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects  Polina Stepensky, MD,
Katie Frith, MD, Anne-Laure Joly, PhD, Cindy S. Ma, PhD, Stuart G
Defective calcium signaling and disrupted CD20–B-cell receptor dissociation in patients with common variable immunodeficiency disorders  Annick A.J.M.
IgG4 production is confined to human IL-10–producing regulatory B cells that suppress antigen-specific immune responses  Willem van de Veen, MSc, Barbara.
Common variable immunodeficiency is associated with a functional deficiency of invariant natural killer T cells  Yifang Gao, PhD, Sarita Workman, MSc,
Hydroxychloroquine preferentially induces apoptosis of CD45RO+ effector T cells by inhibiting autophagy: A possible mechanism for therapeutic modulation.
Early-onset inflammatory bowel disease and common variable immunodeficiency–like disease caused by IL-21 deficiency  Elisabeth Salzer, MD, Aydan Kansu,
Intact IL-12 signaling is necessary for the generation of human natural killer cells with enhanced effector function after restimulation  Venkateswara.
Der p 1–induced CD4+FOXP3+GATA3+ T cells have suppressive properties and contribute to the polarization of the TH2-associated response  Lieke Reubsaet,
Presentation transcript:

Primary T-cell immunodeficiency with functional revertant somatic mosaicism in CD247  Ana V. Marin, MSc, Anaïs Jiménez-Reinoso, MSc, Alejandro C. Briones, MSc, Miguel Muñoz-Ruiz, MSc, Cigdem Aydogmus, MD, Luke J. Pasick, BSc, Jorge Couso, MSc, Marina S. Mazariegos, MSc, Angel F. Alvarez-Prado, MSc, Alfonso Blázquez-Moreno, MSc, Funda E. Cipe, MD, Sule Haskologlu, MD, Figen Dogu, MD, Matías Morín, PhD, Miguel A. Moreno-Pelayo, PhD, Félix García-Sánchez, PhD, Juana Gil-Herrera, MD, PhD, Edgar Fernández-Malavé, PhD, Hugh T. Reyburn, PhD, Almudena R. Ramiro, PhD, Aydan Ikinciogullari, MD, Maria J. Recio, PhD, Jose R. Regueiro, PhD, Beatriz Garcillán, PhD  Journal of Allergy and Clinical Immunology  Volume 139, Issue 1, Pages 347-349.e8 (January 2017) DOI: 10.1016/j.jaci.2016.06.020 Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Patient characterization. A, Peripheral blood phenotype. B, Surface CD3ε expression in the indicated subsets. Numbers indicate % MFI relative to controls. C, Intracellular (i) expression of the indicated CD. Numbers indicate % iCD247− or iCD247+ in iCD3δ+ (T) cells. D, CD247 WB of sorted T cells. Numbers indicate % normalized band intensity relative to control. E, Mutations and predicted proteins. EC, Extracellular; IC, intracellular; MFI, mean fluorescence intensity; SP, signal peptide; TM, transmembrane; WB, Western blot. ***P ≤ .001. Journal of Allergy and Clinical Immunology 2017 139, 347-349.e8DOI: (10.1016/j.jaci.2016.06.020) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Impaired TCR-induced signaling in primary (A and B) and cultured T cells (C and D). % CD69+ cells (Fig 2, A) or CFSE dilution (Fig 2, B) after stimulation with anti-CD3ε for 24 hours or 5 days, respectively. C, Representative pZAP-70 and pERK levels after stimulation with anti-CD3ε (left) and MFI + SEM relative to unstimulated cells of 4 independent experiments (right). D, T-cell growth in allogeneic cultures. CFSE, Carboxyfluorescein diacetate succinimidyl ester; pERK, phospho-extracellular signal–regulated kinase. *P ≤ .05. Journal of Allergy and Clinical Immunology 2017 139, 347-349.e8DOI: (10.1016/j.jaci.2016.06.020) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 Patient characterization. A, Reduced % of recent thymic emigrants defined as CD4+ CD45RA+ CD31+ lymphocytes (age-matched control range,E5 77%-96%). B, Reduced naive T-cell compartment. T-cell maturation stages in CD4+ and CD8bright cells were defined as naive (CD45RO−CD27+), central memory (CD45RO+CD27+), effector memory (CD45RO+CD27−), or effector (CD45RO−CD27−). Control in Fig E1, A and B, was a 20-year-old healthy donor. C, Reduced TCRβ clonality in PBMCs. D, Chest computed axial tomography showing normal-sized thymus. Journal of Allergy and Clinical Immunology 2017 139, 347-349.e8DOI: (10.1016/j.jaci.2016.06.020) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 CD247 deficiency due to a homozygous mutation. A, CD247 gene and protein, including the germline mutation (NCBI/ClinVar: rs672601318, NM_000734.3:c.2T>C and NG_007384.1:g.5146T>C in exon 1) and the next in-frame ATG. B, Top, CD247 mutation and haplotypes based on the indicated microsatellite markers (black = disease-associated chromosome). Bottom, pedigree with haplotypes for studied individuals. Circles, squares, and diamonds indicate females, males, or unknown sex, respectively. Journal of Allergy and Clinical Immunology 2017 139, 347-349.e8DOI: (10.1016/j.jaci.2016.06.020) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E3 In vitro T-cell growth and phenotype. Surface CD3ε expression in cultured T cells with gates and % for CD3εneg, CD3εlow, and CD3εhigh subpopulations at different time points. SSC, Side scatter. Journal of Allergy and Clinical Immunology 2017 139, 347-349.e8DOI: (10.1016/j.jaci.2016.06.020) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E4 Summary of CD247 germline and somatic mutations. Molecular basis of the 3 reported CD247-deficient patients, 1 patient/box: Exon 2,E6 Exon 4,E7 and Exon 1 (present report). EC, Extracellular; IC, intracellular; LP, leader peptide; TM, transmembrane; WT, wild-type. Journal of Allergy and Clinical Immunology 2017 139, 347-349.e8DOI: (10.1016/j.jaci.2016.06.020) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions